Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA)
2016-06-09 18:45
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders
2016-06-08 21:02
Disruptive Technologies and Emerging Trends Drive Life Science Transformation
2016-06-07 21:05
Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Presented at Annual European Congress of Rheumatology (EULAR 2016)
2016-06-07 19:00
Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions
2016-06-07 01:09
Finesse SmartFactory(TM) Platform Featured in Alvotech Opening of New Manufacturing and Lab Facility in Iceland
2016-06-06 21:00
SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment
2016-06-06 20:54
Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016
2016-06-06 20:30
Hutchison China MediTech to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on June 10, 2016
2016-06-06 20:30
Merck Partners with Array BioPharma and Pierre Fabre to Initiate BRAF-mutant CRC Phase III Trial
2016-06-06 08:05
ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Shows Robust Anti-tumor Activity in Advanced Pancreatic Cancer
2016-06-03 22:00
Aptuit Names Henning Steinhagen as EVP Drug Discovery and Development, and Site-Head Verona
2016-06-01 08:00
Governments on Track to Eliminate Viral Hepatitis by 2030
2016-05-31 09:00
WHO Recommends Rapid Test for Extensively Resistant Tuberculosis
2016-05-30 15:15
NUS Engineering team develops novel technology to "print" customised tablets for personalised medicine
2016-05-26 12:08
PharmaBlock Listed on the New Third Board and Plans to File for the GEM Exchanges at the End of 2016
2016-05-25 09:00
Gather Chinese & World Pharmaceutical Entrepreneurs, Write A New Chapter for the Chinese Pharma Industry
2016-05-25 09:00
New Positive Phase III Study for NER1006 - The First 1 Litre PEG-Based Bowel Preparation
2016-05-25 00:30
Takeda Presents Analyses From Vedolizumab Data in Ulcerative Colitis at 2016 Digestive Disease Week (DDW) Annual Meeting
2016-05-24 00:56
Bringing Innovation to Patients: Merck Presents New Advances at ASCO 2016
2016-05-19 06:13
1
241
242
243
244
245
247